Unveiling Collagen's Role in Breast Cancer: Insights into Expression Patterns, Functions and Clinical Implications

Xia Li,Yue Jin,Jian Xue
DOI: https://doi.org/10.2147/ijgm.s463649
IF: 2.145
2024-05-02
International Journal of General Medicine
Abstract:Xia Li, 1 Yue Jin, 1 Jian Xue 2 1 Department of Molecular Diagnosis, Northern Jiangsu People's Hospital, Yangzhou, People's Republic of China; 2 Department of Emergency Medicine, Yizheng People's Hospital, Yangzhou, People's Republic of China Correspondence: Yue Jin, Department of Molecular Diagnosis, Northern Jiangsu People's Hospital, No. 98, Nantong West Road, Yangzhou, Jiangsu Province, People's Republic of China, Email Collagen, the predominant protein constituent of the mammalian extracellular matrix (ECM), comprises a diverse family of 28 members (I–XXVIII). Beyond its structural significance, collagen is implicated in various diseases or cancers, notably breast cancer, where it influences crucial cellular processes including proliferation, metastasis, apoptosis, and drug resistance, intricately shaping cancer progression and prognosis. In breast cancer, distinct collagens exhibit differential expression profiles, with some showing heightened or diminished levels in cancerous tissues or cells compared to normal counterparts, suggesting specific and pivotal biological functions. In this review, we meticulously analyze the expression of individual collagen members in breast cancer, utilizing Transcripts Per Million (TPM) data sourced from the GEPIA2 database. Through this analysis, we identify collagens that deviate from normal expression patterns in breast cancer, providing a comprehensive overview of their expression dynamics, functional roles, and underlying mechanisms. Our findings shed light on recent advancements in understanding the intricate interplay between these aberrantly expressed collagens and breast cancer. This exploration aims to offer valuable insights for the identification of potential biomarkers and therapeutic targets, thereby advancing the prospects of more effective interventions in breast cancer treatment. Keywords: collagen, breast cancer, extracellular matrix, prognostic marker Breast cancer, characterized by its heterogeneity, has become the leading cause of cancer-related deaths among women worldwide, presenting significant challenges to clinical management due to its high morbidity and mortality rates. 1 Despite considerable advancements in breast cancer research, the identification of specific and effective targets remains elusive, rendering the treatment of breast cancer an ongoing challenge. Consequently, there is an urgent need to identify effective diagnostic, prognostic and therapeutic targets. Recent advances in the understanding of breast cancer progression implicate key processes such as epithelial–mesenchymal transition (EMT), the presence of cancer stem cells (CSC), and dysregulation of ECM functions. Among these, ECM is crucial for cell proliferation, differentiation, and tissue homeostasis maintenance. Serving as a pivotal component of the tumor microenvironment, it orchestrates complex tissue interactions influencing tumor growth and metastasis. Acting as a substrate for cell adhesion and a reservoir for growth factors, ECM plays indispensable roles in cancer development and metastasis. It is extensively studied in the context of breast cancer due to its disrupted regulation. 2 Within ECM, proteins, glycoproteins, proteoglycans, and polysaccharides collectively contribute, with collagen standing out as the most abundant component. 3 Collagen constitutes approximately 30% of mammalian total protein, predominantly found in bone and skin. Apart from its structural role in determining tissue mechanical properties and shape, collagen acts as a physical barrier to cell migration and regulates proliferation in both normal and cancer cells. Alterations in its expression can lead to various fibrotic diseases. In breast cancer, increased mammographic density, associated with elevated collagen concentration, is considered to be a significant risk factor for breast cancer development. 4 The expression, organization, and post-translational modifications of collagen types have been reported to be profoundly altered, contributing to a desmoplastic reaction and a stiffened stroma, which in turn influence tumor cell behavior, angiogenesis, and metastatic potential. Meanwhile, collagen restructuring manifests pathological hallmarks of cancer progression, influencing fiber organization, matrix deposition, stiffness, proteolytic products, immune recruitment, and cell phenotype. 5 At present, strategies aimed at inhibiting collagen synthesis or deposition have shown promise in suppressing breast cancer progression. Typically, the collagen superfamily identified in humans comprises at least 28 types (I–XXVIII), exhibiting distinct structural classifications, including fibrous collagen, basal membrane collagen, microfibrous collagen, anchored collagen, hexagonal reticular co -Abstract Truncated-
medicine, general & internal
What problem does this paper attempt to address?